Update On Public Health Issues Related To Polonium-210 Investigation, UK
Main Category: Radiology / Nuclear MedicineAlso Included In: Public Health; Bio-terrorism / Terrorism
Article Date: 26 Feb 2007 - 14:00 PDT
|
|
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The Health Protection Agency is continuing to provide expert advice on the public health issues surrounding the death of Mr. Alexander Litvinenko. Throughout, our primary concern has been to protect the public.
We have carried out an extensive monitoring programme of people and places identified by the police investigation. Our investigations have confirmed there is no public health concern in the open public areas. The monitoring results received so far show that the risk to the general public from any exposure to Polonium-210 (Po-210) is likely to be very low.
Test result update
Category 1
-- 569 people had results 'below reporting level' - below 30 millibecquerels (mBq) per day (natural levels of Po-210 in urine are typically in the range 5-15 mBq per day). It is therefore unlikely that any of these people had been exposed to Po-210
Category 2
-- 85 people had results above 30 mBq per day in their urine, but with a dose less than 1mSv indicating no public health risk, and no health concern to the individual, but probable contact with Po-210
Category 3a
-- 34 people had results above 1 millisievert (mSv), but below 6mSv indicating no public health risk, and no health concern to the individual, but probable contact with Po-210
There are 688 results in categories 1, 2 and 3a and these are NOT of health concern.
Category 3b
-- 16 people had results above 6mSv which are not significant enough to cause any illness in the short term and any increased risk in the long term is likely to be very small
Further information is available on http://www.hpa.org.uk
For information on locations go to the London Resilience Team website at http://www.londonprepared.gov.uk
Visit our radiology / nuclear medicine section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/63960.php>
APA
http://www.medicalnewstoday.com/releases/63960.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



